跳至主要内容
临床试验/JPRN-UMIN000030231
JPRN-UMIN000030231已完成2 期

Phase2 study on the validity of initiating treatment during midtrimester for GDM patients - GDM intervention trial

Yokohama City University Medical Center0 个研究点目标入组 150 人开始时间: 2017年12月5日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 50years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

已完成
2 期
Phase II Clinical Study Evaluating the Efficacy and Safety of Cetuximab Rechallenge in Patients with Wild-Type RAS, Unresectable, Progressive/Recurrent Colorectal Cancer Refractory to Fluoropyrimidines, Oxaliplatin, Irinotecan, Cetuximab and Bevacizumab: The E-Rechallenge TrialColorectal cancer
JPRN-UMIN000016439Public Health Research Foundation50
招募中
不适用
Phase 2 clinical study of evaluation of efficacy of switch to eribulin chemotherapy in patients with locally advanced breast cancer or metastatic breast cancer who are not responsive to combination regimen of Docetaxel, Doxorubicin and Cyclophosphamide (TAC) and continuation of TAC chemotherapy in responding patients to TACocally advanced and/or metastatic breast cancer patients
JPRN-UMIN000015838Saitama Medical Univeristy International Medical Center40
进行中(未招募)
1 期
A phase II clinical trial to assess the effect of HC-SVT-1001 and HC-SVT-1002 in the surgical treatment of nonunions fractures of long bonesAtrophic pseudarthrosisMedDRA version: 21.1Level: PTClassification code 10048617Term: PseudarthrosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2013-000930-37-ESaboratorios Salvat, S.A.12
进行中(未招募)
1 期
Study to assess the value of a nuclear medicine procedure (Tc-99m tetrofosmin SPECT) to identify tumor recurrence in patients with brain tumors after radiation therapy.Patients with high grade brain tumorsMedDRA version: 20.0Level: PTClassification code 10065443Term: Malignant gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2015-005573-21-HUpro-ACTINA S.A.51
进行中(未招募)
1 期
Study to assess the value of a nuclear medicine procedure (Tc-99m tetrofosmin SPECT) to identify tumor recurrence in patients with brain tumors after radiation therapy.Patients with high grade brain tumorsMedDRA version: 20.0Level: PTClassification code 10065443Term: Malignant gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2015-005573-21-FRpro-ACTINA S.A.30
Phase2 study on the validity of initiating treatment... | 临床试验